ArticleFrontiers in pediatrics2026
Perioperative anesthetic considerations and outcomes in Crouzon syndrome: a retrospective analysis of Le Fort III advancement surgery.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Le Fort III osteotomy and advancement in children with Crouzon syndrome represents a crucial therapeutic modality for severe midface hypoplasia. These procedures are highly invasive and associated with significant intraoperative hemorrhage and difficult airway management, posing substantial anesthetic risks. This study aims to summarize perioperative anesthetic management strategies, describe perioperative outcomes, and analyze risk factors for postoperative complications in this specific population. Methods: Medical records of consecutive children with Crouzon syndrome undergoing Le Fort III osteotomy and advancement were retrospectively reviewed from Peking University International Hospital between December 2017 and January 2026. Inclusion criteria were: (i) diagnosis of Crouzon syndrome; (ii) underwent Le Fort III osteotomy and advancement; and (iii) age younger than 18 years at the time of surgery. Data extracted included demographics, perioperative management, complications, fluid and transfusion volumes, and length of stay. Risk factors for postoperative complications were analyzed using univariate and multivariate logistic regression. Results: A total of 47 children (male, 24) were enrolled, with a median age of 6 years (IQR, 6-10 years). The median operative time was 215 minutes (IQR, 180-279 minutes), intraoperative blood loss was 14.3 mL/kg, and the allogeneic blood transfusion rate was 68.1%. Postoperative complications occurred in 29.8% of patients (14/47). Multivariate logistic regression analysis identified operative duration (odds ratio [OR] = 1.010; 95% confidence interval [CI], 1.001-1.021; Conclusion: Anesthetic management for Le Fort III osteotomy in children with Crouzon syndrome requires meticulous attention to difficult airway anatomy and significant intraoperative hemorrhage. Prolonged operative duration significantly increase the risk of postoperative complications. Future research should prioritize multicenter prospective cohort designs to establish larger, more comprehensive databases capable of validating the present findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.